Cordasco Financial Network - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 216 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cordasco Financial Network ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$5,000
-28.6%
1,0000.0%0.00%
-40.0%
Q3 2021$7,000
-41.7%
1,0000.0%0.01%
-50.0%
Q3 2020$12,000
-55.6%
1,0000.0%0.01%
-60.0%
Q2 2020$27,000
+237.5%
1,000
-1.0%
0.02%
+177.8%
Q1 2020$8,000
+166.7%
1,010
+1.0%
0.01%
+200.0%
Q4 2019$3,000
+50.0%
1,0000.0%0.00%
+50.0%
Q3 2019$2,000
-33.3%
1,0000.0%0.00%
-33.3%
Q2 2019$3,000
-25.0%
1,0000.0%0.00%
-25.0%
Q1 2019$4,000
+100.0%
1,000
+100.0%
0.00%
+100.0%
Q4 2018$2,000
-33.3%
5000.0%0.00%
-33.3%
Q3 2018$3,000
+50.0%
5000.0%0.00%
+50.0%
Q2 2018$2,0000.0%5000.0%0.00%0.0%
Q1 2018$2,0000.0%5000.0%0.00%0.0%
Q4 2017$2,000
-33.3%
5000.0%0.00%
-33.3%
Q3 2017$3,000
-25.0%
5000.0%0.00%
-40.0%
Q2 2017$4,000
+33.3%
5000.0%0.01%
+66.7%
Q1 2017$3,0005000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Round Table Services, LLC 129,500$1,207,0000.72%
STONERIDGE INVESTMENT PARTNERS LLC 252,376$2,352,0000.34%
Bellevue Group AG 155,000$1,445,0000.26%
WASATCH ADVISORS LP 1,861,553$17,350,0000.26%
Blue Clay Capital Management, LLC 13,000$121,0000.14%
Virtus ETF Advisers LLC 24,058$224,0000.11%
EMERALD ADVISERS, LLC 203,737$1,899,0000.08%
Vident Investment Advisory, LLC 63,383$591,0000.08%
Thomas J. Herzfeld Advisors, Inc. 15,000$140,0000.08%
GSA CAPITAL PARTNERS LLP 94,400$880,0000.05%
View complete list of INOVIO PHARMACEUTICALS INC shareholders